Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

Julia Hoy, Teresa Neeman, Robin Stuart-Harris, Alison Davis*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    5 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology